Technical Analysis for CLSD - Clearside Biomedical, Inc.

Grade Last Price % Change Price Change
D 2.45 -5.77% -0.15
CLSD closed down 5.77 percent on Wednesday, May 12, 2021, on 41 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: May 17
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical CLSD trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Below Lower BB Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish -5.77%
Lower Bollinger Band Touch Weakness -5.77%
Oversold Stochastic Weakness -5.77%
MACD Bearish Centerline Cross Bearish -4.30%
Oversold Stochastic Weakness -4.30%
Stochastic Reached Oversold Weakness -9.93%
Inside Day Range Contraction -9.93%
Older End-of-Day Signals for CLSD ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 17 hours ago
60 Minute Opening Range Breakdown about 18 hours ago
Fell Below Lower Bollinger Band about 18 hours ago
Lower Bollinger Band Support about 18 hours ago
Possible Inside Day about 19 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Clearside BioMedical, Inc., a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. The company was founded in 2011 and is headquartered in Alpharetta, Georgia.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Eye Macular Degeneration Ophthalmology Related Macular Degeneration Retina Macular Edema Vein Wet Age Related Macular Degeneration Drug Therapies Uveitis Macula Of Retina Adverum Biotechnologies Non Infectious Uveitis Retinal Vein Occlusion

Is CLSD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.53
52 Week Low 1.25
Average Volume 252,051
200-Day Moving Average 2.36
50-Day Moving Average 2.78
20-Day Moving Average 2.83
10-Day Moving Average 2.75
Average True Range 0.23
ADX 18.98
+DI 13.35
-DI 17.59
Chandelier Exit (Long, 3 ATRs ) 2.60
Chandelier Exit (Short, 3 ATRs ) 3.10
Upper Bollinger Band 3.22
Lower Bollinger Band 2.45
Percent B (%b) 0.0
BandWidth 27.13
MACD Line -0.06
MACD Signal Line 0.00
MACD Histogram -0.0515
Fundamentals Value
Market Cap 118.47 Million
Num Shares 48.4 Million
EPS -1.96
Price-to-Earnings (P/E) Ratio -1.25
Price-to-Sales 9.81
Price-to-Book 12.80
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.78
Resistance 3 (R3) 2.82 2.74 2.72
Resistance 2 (R2) 2.74 2.66 2.72 2.71
Resistance 1 (R1) 2.60 2.61 2.56 2.56 2.69
Pivot Point 2.52 2.52 2.50 2.50 2.52
Support 1 (S1) 2.38 2.44 2.34 2.34 2.21
Support 2 (S2) 2.30 2.39 2.29 2.19
Support 3 (S3) 2.16 2.30 2.18
Support 4 (S4) 2.12